Literature DB >> 31386828

A neutral lipid-enriched diet improves myelination and alleviates peripheral nerve pathology in neuropathic mice.

Ye Zhou1, Hannah Bazick1, Joshua R Miles2, Alexander I Fethiere1, Mohammed Omar Al Salihi1, Sergio Fazio2, Hagai Tavori2, Lucia Notterpek3.   

Abstract

Charcot-Marie-Tooth (CMT) diseases comprise a genetically heterogeneous group of hereditary peripheral neuropathies. Trembler J (TrJ) mice carry a spontaneous mutation in peripheral myelin protein 22 (PMP22) and model early-onset, severe CMT type 1E disease. Recent studies indicate that phospholipid substitution, or cholesterol-enriched diet, benefit myelinated nerves, however such interventions have not been tested in early-onset dysmyelinating neuropathies. Here, we examined the lipid profile of peripheral nerves from 6-month-old TrJ mice with advanced neuropathy and tested the impact of a 6-week-long neutral lipid-enriched high-fat diet (HFD) on neuropathy progression in young, newly-weaned mice. Oil Red O staining showed pronounced neutral lipid accumulation in nerves from 6-month-old TrJ mice, along with elevated levels of key cholesterol and triglyceride transport proteins including apoE, LRP1 and ABCA1, compared with wild type (Wt). In young mice, the short-term HFD intervention increased serum cholesterol levels without impacting triglycerides, or body and liver weights. Tissue samples from neuropathic TrJ mice showed improvements in the maintenance of myelinated axons after the 6-week-long dietary intervention, and this effect was evident both in the sciatic and phrenic nerves. Concomitantly, aberrant Schwann cell proliferation was attenuated, as detected by reduction in mitotic markers and in c-Jun expression. Nerves from HFD-fed TrJ mice contained fewer macrophages, with a normalized count of CD11b + cells. In addition, we detected an increase in neutral lipids in the nerve endoneurium and a trend toward normalization of apoE, LRP1, and ABCA1 expression after the HFD feeding. Together, these results demonstrate the beneficial influence of a short-term neutral lipid-enriched diet on neuropathy progression in young TrJ mice and support further work in investigating the potential benefits of dietary lipids on hereditary neuropathies.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cholesterol; Lipid-enriched diet; Macrophage; Peripheral myelin protein 22; Peripheral neuropathy; Trembler J mice

Mesh:

Year:  2019        PMID: 31386828     DOI: 10.1016/j.expneurol.2019.113031

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  6 in total

Review 1.  Mechanisms and Treatments in Demyelinating CMT.

Authors:  Vera Fridman; Mario A Saporta
Journal:  Neurotherapeutics       Date:  2021-11-08       Impact factor: 6.088

2.  Ceramide contributes to pathogenesis and may be targeted for therapy in VCP inclusion body myopathy.

Authors:  Lan Weiss; Kwang-Mook Jung; Angele Nalbandian; Katrina Llewellyn; Howard Yu; Lac Ta; Isabela Chang; Marco Migliore; Erica Squire; Faizy Ahmed; Daniele Piomelli; Virginia Kimonis
Journal:  Hum Mol Genet       Date:  2021-02-25       Impact factor: 6.150

3.  Curcumin and Ethanol Effects in Trembler-J Schwann Cell Culture.

Authors:  Lucia Vázquez Alberdi; Gonzalo Rosso; Lucía Velóz; Carlos Romeo; Joaquina Farias; María Vittoria Di Tomaso; Miguel Calero; Alejandra Kun
Journal:  Biomolecules       Date:  2022-03-29

4.  Peripheral myelin protein 22 preferentially partitions into ordered phase membrane domains.

Authors:  Justin T Marinko; Anne K Kenworthy; Charles R Sanders
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-08       Impact factor: 11.205

Review 5.  Myelin Fat Facts: An Overview of Lipids and Fatty Acid Metabolism.

Authors:  Yannick Poitelon; Ashley M Kopec; Sophie Belin
Journal:  Cells       Date:  2020-03-27       Impact factor: 6.600

6.  Intraepineurial fat quantification and cross-sectional area analysis of the sciatic nerve using MRI in Charcot-Marie-Tooth disease type 1A patients.

Authors:  Hyun Su Kim; Ji Hyun Lee; Young Cheol Yoon; Min Jae Cha; Soo Hyun Nam; Hye Mi Kwon; Seonwoo Kim; Hojeong Won; Byung-Ok Choi
Journal:  Sci Rep       Date:  2021-11-02       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.